Skip to main content

Find Clinical Trials

Home
Conditions
Lipid Metabolism Disorders

Clinical trial condition

Lipid Metabolism Disorders

Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.

3,310 public trials 329 recruiting studies

Refine in advanced search Browse all conditions

Lipid Metabolism Disorders trial results

Completed

Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy in Japan

NCT01812707

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Investigational Site Number 392002 Koganeishi, Japan

Investigational Site Number 392001 Shinjuku-Ku, Japan

Investigational Site Number 392003 Suita-Shi, Japan

Investigational Site Number 392004 Suita-Shi, Japan

View Trial Details

Completed

ADME Study in Healthy Male Subjects With TA-8995

NCT02408055

Conditions: Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
Locations: Covance Clinical Research Unit Ltd Leeds, United Kingdom

View Trial Details

Completed

MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use

NCT01050465

Conditions: Acne Vulgaris, Acneiform Eruptions, Allergic Rhinitis, +145 more
Locations: Not specified

View Trial Details

Completed

Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow

NCT00634608

Conditions: Allergic Rhinitis, Anxiety, Anxiety Disorders, +99 more
Locations: University of Missouri, Department of Internal Medicine Columbia, Missouri, United States

View Trial Details

Completed

Intestines and Liver Contribution to Fasting Postprandial Hypertriglyceridemia

NCT02898142

Conditions: Dyslipidemias, Glucose Metabolism Disorders, Hyperinsulinism, +7 more
Locations: Pitié Salpetriere Hospital Paris, France

View Trial Details

Completed

A Study to Evaluate the Effects of Dietary Fiber on Blood Lipids in Men and Women

NCT02835872

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Biofortis Addison, Illinois, United States

View Trial Details

Completed

Ascending Dose Study of the Safety and Tolerability of Alirocumab (SAR236553/REGN727) in Japanese Healthy Volunteers

NCT01448317

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Sanofi-Aventis Administrative Office Tokyo, Japan

View Trial Details

Completed

An Open-Label, Dose Escalation Study to Evaluate the Safety and the Pharmacokinetics of Oral PRX-112

NCT02107846

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations: Shaare Zedek Medical Center Jerusalem, Israel

View Trial Details

Completed

Effect of Alirocumab (SAR236553/REGN727) Administered on Top of Ezetimibe or Fenofibrate on Lipid Profiles in Healthy Subjects

NCT01723735

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Investigational Site Number 250001 Rennes, France

Investigational Site Number 250002 Rueil-Malmaison, France

View Trial Details

Completed

Nattokinase Supplementation and Hemostatic Factors

NCT02913170

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Laboratory of Clinical Nutrigenetics/Nutrigenomics, Yonsei University. Seoul, South Korea

View Trial Details